Choose which categories of cookies you allow. Strictly necessary cookies are always on.
Required for core site functionality, security and your session. Always active.
Help us understand how visitors use the site (e.g. Google Analytics) so we can improve it.
Used to measure campaigns and show you relevant ads on other sites (e.g. LinkedIn, Google Ads).
Urology Devices Market Analysis size 2021 was recorded $31174.87 Million whereas by the end of 2026 it will reach $44018.65 Million. According to the author, by 2033 Urology Devices market size will become $71000 Million. Urology Devices market will be growing at a CAGR of 7.144% during 2026 to 2033. Download a free sample with data verified by Supriya Yadav
| Data Timeline | Historical Data: 2022–2025 | Base Year: 2025 | Forecast Period: 2026–2034 |
|---|---|
| Type Segment | Dialysis Devices, Endoscopy Devices, Lasers, Robotic Devices, Lithotripsy Devices |
| Application Segment | Kidney Diseases, Urological Cancer, Pelvic Organ Prolapse, Benign Prostatic Hyperplasia |
| End User Segment | Hospitals, Clinics, Dialysis Centers, Ambulatory Surgical Centers |
|---|---|
| Regions & Countries |
|
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
| Region / Country | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|---|---|---|---|
| Global | $ 31174.9 Million | $ 41084.3 Million | $ 71354.1 Million | 7.144% |
| North America | $ 11908.8 Million | $ 15427.2 Million | $ 25901.5 Million | 6.692% |
| United States | $ 9562.76 Million | $ 12335.6 Million | $ 20521.8 Million | 6.569% |
| Canada | $ 1488.6 Million | $ 1973.13 Million | $ 3473.4 Million | 7.325% |
| Mexico | $ 857.43 Million | $ 1118.47 Million | $ 1906.35 Million | 6.893% |
| Europe | $ 6733.77 Million | $ 8668.79 Million | $ 14556.2 Million | 6.693% |
| United Kingdom | $ 969.66 Million | $ 1265.64 Million | $ 2179.07 Million | 7.027% |
| France | $ 906.37 Million | $ 1145.15 Million | $ 1842.82 Million | 6.127% |
| Germany | $ 1392.54 Million | $ 1827.38 Million | $ 3228.57 Million | 7.374% |
| Italy | $ 681.46 Million | $ 866.88 Million | $ 1417.78 Million | 6.342% |
| Russia | $ 413.45 Million | $ 506.26 Million | $ 770.03 Million | 5.382% |
| Spain | $ 573.72 Million | $ 746.38 Million | $ 1280.95 Million | 6.985% |
| Sweden | $ 465.98 Million | $ 604.21 Million | $ 1026.94 Million | 6.855% |
| Denmark | $ 235.68 Million | $ 299.07 Million | $ 489.09 Million | 6.341% |
| Switzerland | $ 318.51 Million | $ 400.5 Million | $ 639.02 Million | 6.014% |
| Luxembourg | $ 60.6 Million | $ 74.12 Million | $ 111.21 Million | 5.203% |
| Rest of Europe | $ 715.8 Million | $ 933.2 Million | $ 1570.76 Million | 6.725% |
| Asia Pacific | $ 8479.56 Million | $ 11524.1 Million | $ 21334.9 Million | 8.003% |
| China | $ 2908.49 Million | $ 3975.83 Million | $ 7456.54 Million | 8.178% |
| Japan | $ 1195.62 Million | $ 1584.57 Million | $ 2765 Million | 7.207% |
| South Korea | $ 729.24 Million | $ 966.88 Million | $ 1704.66 Million | 7.345% |
| India | $ 1356.73 Million | $ 1895.72 Million | $ 3712.27 Million | 8.763% |
| Australia | $ 415.5 Million | $ 534.72 Million | $ 893.93 Million | 6.634% |
| Singapore | $ 237.43 Million | $ 329.59 Million | $ 629.38 Million | 8.422% |
| Taiwan | $ 364.62 Million | $ 485.17 Million | $ 869.61 Million | 7.567% |
| South East Asia | $ 432.46 Million | $ 609.63 Million | $ 1201.15 Million | 8.847% |
| Rest of APAC | $ 839.48 Million | $ 1142.04 Million | $ 2102.34 Million | 7.926% |
| South America | $ 1839.32 Million | $ 2456.84 Million | $ 4368.3 Million | 7.459% |
| Brazil | $ 658.48 Million | $ 874.64 Million | $ 1538.51 Million | 7.315% |
| Argentina | $ 380.74 Million | $ 516.67 Million | $ 950.98 Million | 7.924% |
| Colombia | $ 281.42 Million | $ 375.26 Million | $ 642.31 Million | 6.949% |
| Peru | $ 160.02 Million | $ 212.47 Million | $ 372.53 Million | 7.271% |
| Chile | $ 185.77 Million | $ 249.86 Million | $ 451.25 Million | 7.669% |
| Rest of South America | $ 172.9 Million | $ 227.95 Million | $ 412.72 Million | 7.703% |
| Middle East | $ 1215.82 Million | $ 1620.78 Million | $ 2866.29 Million | 7.387% |
| Saudi Arabia | $ 325.84 Million | $ 435.83 Million | $ 775.62 Million | 7.471% |
| Turkey | $ 265.05 Million | $ 356.41 Million | $ 644.06 Million | 7.677% |
| UAE | $ 170.22 Million | $ 233.23 Million | $ 436.82 Million | 8.16% |
| Egypt | $ 148.33 Million | $ 194.66 Million | $ 330.2 Million | 6.829% |
| Qatar | $ 121.58 Million | $ 160.31 Million | $ 278.35 Million | 7.14% |
| Rest of Middle East | $ 184.81 Million | $ 240.35 Million | $ 401.25 Million | 6.616% |
| Africa | $ 997.6 Million | $ 1386.59 Million | $ 2326.86 Million | 6.685% |
| East Africa | xxxx | xxxx | xxxx | xxxx |
| West Africa | xxxx | xxxx | xxxx | xxxx |
| North Africa | xxxx | xxxx | xxxx | xxxx |
| South Africa | $ 369.44 Million | $ 524.04 Million | $ 922.68 Million | 7.327% |
A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.
Unlock full regional dataset →Endoscopy devices are projected to have the largest market share during the forecast period. Based on product, globally, the urology devices market is segmented into dialysis, endoscopy, lasers, robotic, and lithotripsy devices. The endoscopy devices segment holds the largest market share due to the rising growth of urolithiasis and celiac diseases. The endoscopic device scans the digestive system for blockages, tumors, ulcers, and inflammation. Urinary endoscopy is the safest and low-level risk procedure in genitourinary surgery. Technical advancements in these devices to avoid infection during surgeries have gained the potential to drive market growth. Therefore, this segment is expected to drive the market growth of urology devices. Dialysis Devices Endoscopy Devices Lasers Robotic Devices Lithotripsy Devices
Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.
To learn more about market share and segmentation, request the free sample pages.
LiNA Medical USA, a specialized in minimally-invasive medical devices in the field of urology, and UroCure a developer of the sling treatment for female stress urinary incontinence, partnered to grow a strategic sales distribution. They developed a surgical solution for female stress urinary incontinence. This solution mitigated the effects of stress urinary incontinence in women.
Baxter International Inc., a global innovator in renal care announced FDA clearance of the Homechoice Claria, an automated peritoneal dialysis (APD) system with the Sharesouce connectivity platform. This expanded the accessibility to home-based therapy for US patients with kidney failure.
| Top Companies (In no particular order) | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Becton Dickinson and Company (US) | ••• | ••• | ••• | ••• |
| Cardinal Health (US) | ••• | ••• | ••• | ••• |
| B. Braun Melsungen AG (Germany) | ••• | ••• | ••• | ••• |
| Intuitive Surgical (US) | ••• | ••• | ••• | ••• |
| Medtronic plc (Ireland) | ••• | ••• | ••• | ••• |
| Boston Scientific Corporation (US) | ••• | ••• | ••• | ••• |
| Stryker Corporation (US) | ••• | ••• | ••• | ••• |
| KARL STORZ (Germany) | ••• | ••• | ••• | ••• |
| Cook Medical (US) | ••• | ••• | ••• | ••• |
| Olympus Corporation (Japan) | ••• | ••• | ••• | ••• |
| Baxter International Inc. (US) | ••• | ••• | ••• | ••• |
We Provide Regional Breakdown of this Companies and Company specific to any Country, Region, Product/ service as well. We cover market share analysis for publicly listed companies as well as privately held companies, subject to data availability.
Request company profile for validation →The global urology devices market is poised for robust growth, driven by a confluence of factors including the rising prevalence of urological disorders such as kidney stones, benign prostatic hyperplasia (BPH), and urinary incontinence. An aging global population, which is more susceptible to such conditions, further fuels market expansion. Technological advancements are playing a pivotal role, with a significant shift towards minimally invasive procedures, robotic-assisted surgeries, and the development of more effective and patient-friendly devices. While North America currently dominates the market, the Asia Pacific region is emerging as the fastest-growing market, thanks to improving healthcare infrastructure, rising disposable incomes, and growing awareness. The market is projected to expand significantly, reaching over $71 billion by 2033, demonstrating substantial opportunities for innovation and market penetration.
Manufacturers should prioritize R&D investments in minimally invasive and robotic technologies to meet evolving clinical demands. Strategic expansion into high-growth Asia Pacific markets through partnerships and localized product strategies is crucial. Furthermore, developing a tiered product portfolio with both premium and cost-effective solutions will enable penetration across diverse economic landscapes, from developed nations to emerging markets. Building strong post-market surveillance and educational programs can help mitigate risks associated with device use and build clinician trust.
Urology devices are used to diagnose and treat urological diseases or disorders such as urethral malignancies, urolithiasis, kidney diseases, and bladder disorders. They include various types of equipment, catheters, consumables, and dilators. The tools used in surgical diagnosis are cystoscopy, ureteroscopy, microsurgery, and laser lithotripsy devices. Urology is also termed genitourinary surgery.
As per Cognitive's Research Analyst, Urology Devices are products used for diagnosing and treating disorders of the urinary tract and male reproductive system. They play an essential role in addressing conditions like chronic kidney disease, urologic cancers, and incontinence, thereby improving patient outcomes and quality of life.
Looking at the Historical Growth The global market expanded from $31174.87 million in 2021 to an estimated $44018.65 million in 2026 due to the rising incidence of urological disorders among an aging global population. Regionally, North America grew from $11908.8 million in 2021 to $16459.68 million in 2026, while Asia Pacific progressed from $8479.56 million to $12446.39 million over the same period.
Currently in 2026, North America holds a commanding 37.39% of the global market, driven by advanced healthcare infrastructure, significant healthcare spending, and favorable reimbursement policies. The minimally invasive surgical procedures segment remains the primary consumer of Urology Devices. Additionally Asia Pacific is set to be the fastest-growing region, exhibiting the highest CAGR of 8.003%, fueled by improving healthcare infrastructure, rising disposable incomes, and increasing patient awareness.
The market is witnessing a definitive shift towards minimally invasive and robotic-assisted surgical techniques, driven by benefits like reduced pain, shorter hospital stays, and faster patient recovery. Ongoing innovation in advanced medical technologies is also leading, focusing on improving treatment efficacy and patient safety.
In the future, The global Urology Devices market will reach to $71000 million by 2033, expanding at a compound annual growth rate of 7.144% from 2021, primarily driven by the growing patient base for urological conditions and increased healthcare spending worldwide. Ongoing innovation in urological device technology and the strong trend towards less invasive treatment options will also contribute significantly.
Supriya is a Team Lead at Cognitive Market Research & Consulting, leading research initiatives and strategic intelligence projects across the Healthcare, Pharmaceuticals, and Medical Devices & Consumables sectors. With more than two years of experience in market research and data analysis, she plays a key role in helping organizations navigate complex healthcare ecosystems, identify emerging opportunities, and make informed business decisions through data-driven insights and market intelligence.
Combining expertise in both primary and secondary research methodologies with a strong academic foundation in Marketing and Finance, Supriya oversees the execution of market assessments, competitive intelligence studies, forecasting models, stakeholder interviews, trend analysis, and custom consulting engagements. She collaborates with healthcare providers, pharmaceutical manufacturers, medical device companies, industry experts, and other key stakeholders to gather firsthand market perspectives while validating findings through extensive research. Her ability to interpret clinical, commercial, and market data enables clients to better understand industry developments, regulatory influences, innovation trends, and competitive dynamics.
In her leadership role, she manages end-to-end research projects and guides cross-functional teams in delivering high-quality market reports, consulting solutions, and strategic studies. Her expertise in market estimation, forecasting, and analytical modeling helps organizations evaluate market potential, assess growth opportunities, strengthen competitive positioning, and support strategic planning initiatives. By transforming complex healthcare and life sciences data into actionable business intelligence, she enables clients to make confident decisions in rapidly evolving market environments.
Driven by a passion for healthcare innovation and continuous professional development, Supriya remains committed to staying ahead of industry trends, technological advancements, and changing market conditions. Her leadership, analytical mindset, and dedication to research excellence help organizations mitigate risks, capitalize on emerging opportunities, and achieve sustainable growth across the global healthcare and life sciences landscape.
★ Reviews
Rate this report
| Type | Dialysis Devices, Endoscopy Devices, Lasers, Robotic Devices, Lithotripsy Devices |
|---|---|
| Application | Kidney Diseases, Urological Cancer, Pelvic Organ Prolapse, Benign Prostatic Hyperplasia |
| End User | Hospitals, Clinics, Dialysis Centers, Ambulatory Surgical Centers |
| List of Competitors | Becton Dickinson and Company (US), Cardinal Health (US), B. Braun Melsungen AG (Germany), Intuitive Surgical (US), Medtronic plc (Ireland), Boston Scientific Corporation (US), Stryker Corporation (US), KARL STORZ (Germany), Cook Medical (US), Olympus Corporation (Japan), Baxter International Inc. (US) |
Cognitive Market Research and Consulting "The Full Truth" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Urology Devices Market Analysis Market analysis.
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
Explore the global urology devices market trends, growth drivers, and 2035 forecast. Discover market size, product segments, and strategic insights provided by Cognitive Market Research and Consulting to optimize your healthcare investments and product pipelines.
Explore the top emerging and established urology device companies in 2025, including Zenflow, Promaxo, Neuspera, Boston Scientific, Medtronic, and KARL STORZ, driving innovation in minimally invasive therapies, robotics, and AI-assisted diagnostics.
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Urology Devices Market Analysis market.
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the urology devices market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.
